Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study

Carlos Pineda, Luis M Amezcua-Guerra, Carla Solano, Pedro Rodriguez-Henríquez, Cristina Hernández-Díaz, Angelica Vargas, Fritz Hofmann, Marwin Gutiérrez, Carlos Pineda, Luis M Amezcua-Guerra, Carla Solano, Pedro Rodriguez-Henríquez, Cristina Hernández-Díaz, Angelica Vargas, Fritz Hofmann, Marwin Gutiérrez

Abstract

Introduction: In this study, we aimed to investigate ultrasonographic (US) changes suggestive of gouty arthritis in the hyaline cartilage, joints and tendons from asymptomatic individuals with hyperuricemia.

Methods: We conducted a cross-sectional, controlled study including US examinations of the knees and first metatarsal-phalangeal joints (first MTPJs), as well as of the tendons and enthesis of the lower limbs. Differences were estimated by χ² or unpaired t-tests as appropriate. Associations were calculated using the Spearman's correlation coefficient rank test.

Results: Fifty asymptomatic individuals with hyperuricemia and 52 normouricemic subjects were included. Hyperechoic enhancement of the superficial margin of the hyaline cartilage (double contour sign) was found in 25% of the first MTPJs from hyperuricemic individuals, in contrast to none in the control group (P < 0.0001). Similar results were found on the femoral cartilage (17% versus 0; P < 0.0001). Patellar enthesopathy (12% versus 2.9%; P = 0.01) and tophi (6% versus 0; P = 0.01) as well as Achilles enthesopathy (15% versus 1.9%; P = 0.0007) were more frequent in hyperuricemic than in normouricemic individuals. Intra-articular tophi were found in eight hyperuricemic individuals but in none of the normouricemic subjects (P = 0.003).

Conclusions: These data demonstrate that morphostructural changes suggestive of gouty arthritis induced by chronic hyperuricemia frequently occur in both intra- and extra-articular structures of clinically asymptomatic individuals.

Figures

Figure 1
Figure 1
The double contour sign. Hyperechoic enhancement of the chondrosynovial interface secondary to the monosodium urate crystal deposition. (A) Transversal scan of the femoral cartilage surface. (B) Longitudinal view of the plantar aspect in the first metatarsal-phalangeal joint.

References

    1. Yamamoto T. Definition and classification of hyperuricemia. Nippon Rinsho. 2008;66:636–640.
    1. Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med. 2008;75(Suppl 5):S13–S16. doi: 10.3949/ccjm.75.Suppl_5.S13.
    1. Neogi T. Asymptomatic hyperuricemia: perhaps not so benign? J Rheumatol. 2008;35:734–737.
    1. Rouault T, Caldwell DS, Holmes EW. Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. Arthritis Rheum. 1982;25:209–212. doi: 10.1002/art.1780250215.
    1. Puig JG, de Miguel E, Castillo MC, Rocha AL, Martínez MA, Torres RJ. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids. 2008;27:592–595. doi: 10.1080/15257770802136040.
    1. Filippucci E, Scirè CA, Delle Sedie A, Iagnocco A, Riente L, Meenagh G, Gutierrez M, Bombardieri S, Valesini G, Montecucco C, Grassi W. Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol. 2010;28:2–5.
    1. Wright SA, Filippucci E, McVeigh C, Grey A, McCarron M, Grassi W, Wright GD, Taggart AJ. High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study. Ann Rheum Dis. 2007;66:859–864. doi: 10.1136/ard.2006.062802.
    1. Dalbeth N, McQueen FM. Use of imaging to evaluate gout and other crystal deposition disorders. Curr Opin Rheumatol. 2009;21:124–131. doi: 10.1097/BOR.0b013e3283257b6c.
    1. Schueller-Weidekamm C, Schueller G, Aringer M, Weber M, Kainberger F. Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol. 2007;62:437–443. doi: 10.1016/j.ejrad.2006.12.005.
    1. Grassi W, Meenagh G, Pascual E, Filippucci E. "Crystal clear": sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 2006;36:197–202. doi: 10.1016/j.semarthrit.2006.08.001.
    1. Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford) 2007;46:1116–1121. doi: 10.1093/rheumatology/kem058.
    1. Keen HI, Brown AK, Wakefield RJ, Conaghan PG. MRI and musculoskeletal ultrasonography as diagnostic tools in early arthritis. Rheum Dis Clin North Am. 2005;31:699–714. doi: 10.1016/j.rdc.2005.07.002.
    1. Carter JD, Kedar RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S, Valeriano J, Vasey FB, Ricca LR. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology (Oxford) 2009;48:1442–1446. doi: 10.1093/rheumatology/kep278.
    1. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, Wakefield RJ, Manger B. Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis. 2001;60:641–649. doi: 10.1136/ard.60.7.641.
    1. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, O'Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG. OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485–2487.
    1. Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT. Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford) 2010;49:1929–1934. doi: 10.1093/rheumatology/keq184.
    1. Neogi T, Ellison RC, Hunt S, Terkeltaub R, Felson DT, Zhang Y. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol. 2009;36:378–384. doi: 10.3899/jrheum.080955.
    1. Rodrigues TC, Maahs DM, Johnson RJ, Jalal DI, Kinney GL, Rivard C, Rewers M, Snell-Bergeon JK. Serum acid uric predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care. 2010;33:2471–2473. doi: 10.2337/dc10-1007.
    1. Gutierrez M, Filippucci E, Salaffi F, Grassi W. The current role of ultrasound in the assessment of crystal-related arthropathies. Reumatismo. 2009;61:216–221.
    1. Burt HM, Dutt YC. Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates. Ann Rheum Dis. 1986;45:858–864. doi: 10.1136/ard.45.10.858.
    1. Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved. Rheumatol Int. 2010;30:495–503. doi: 10.1007/s00296-009-1002-8.
    1. Haslam KE, McCann LJ, Wyatt S, Wakefield RJ. The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study. Rheumatology (Oxford) 2010;49:123–127. doi: 10.1093/rheumatology/kep339.
    1. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–2967. doi: 10.1002/art.23945.
    1. Gutierrez M, Filippucci E, De Angelis R, Filosa G, Kane D, Grassi W. A sonographic spectrum of psoriatic arthritis: "the five targets". Clin Rheumatol. 2010;29:133–142. doi: 10.1007/s10067-009-1292-y.
    1. Iagnocco A, Modesti M, Priori R, Alessandri C, Perella C, Takanen S, Valesini G. Subclinical synovitis in primary Sjögren's syndrome: an ultrasonographic study. Rheumatology (Oxford) 2010;49:1153–1157. doi: 10.1093/rheumatology/keq076.

Source: PubMed

3
Iratkozz fel